Lung Cancers Completed Phase 1 Trials for Denileukin diftitox (DB00004)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00128622Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic CancerTreatment